Active Stocks
Thu Mar 28 2024 15:59:33
  1. Tata Steel share price
  2. 155.90 2.00%
  1. ICICI Bank share price
  2. 1,095.75 1.08%
  1. HDFC Bank share price
  2. 1,448.20 0.52%
  1. ITC share price
  2. 428.55 0.13%
  1. Power Grid Corporation Of India share price
  2. 277.05 2.21%
Business News/ Industry / Manufacturing/  USFDA inspects Gagillapur facility of Granules India
BackBack

USFDA inspects Gagillapur facility of Granules India

Inspection was triggered by one of the applicant's abbreviated new drug application filing

Shares of Granules India on Monday closed at Rs908.70 per scrip on BSE, up 3.43% from its previous close. Premium
Shares of Granules India on Monday closed at Rs908.70 per scrip on BSE, up 3.43% from its previous close.

New Delhi: Drug maker Granules India on Monday said US health regulator FDA has inspected its Gagillapur manufacturing facility near Hyderabad and did not find any deviation from good manufacturing norms. “The United States Food and Drug Administration (USFDA) had inspected Gagillapur facility last week and the inspection concluded with no observations," Granules India said in a filing to BSE.

The inspection was triggered by one of the applicant’s abbreviated new drug application (ANDA) filing, it added.

The company manufactures pharmaceutical formulation intermediates (PFIs) and finished dosages at its Gagillapur facility. Shares of Granules India on Monday closed at Rs908.70 per scrip on BSE, up 3.43% from its previous close.

Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!

Catch all the Industry News, Banking News and Updates on Live Mint. Download The Mint News App to get Daily Market Updates.
More Less
Published: 16 Mar 2015, 08:34 PM IST
Next Story footLogo
Recommended For You
Manufacturing Stocks
₹557.550.52%
ITC
₹4280.13%
₹2,987.85-0.37%
₹152.852%
Switch to the Mint app for fast and personalized news - Get App